Odyssean »

Nu Hldgs Ltd Ord Shs Cl A shares owned by Odyssean

Quarter-by-quarter ownership of Nu Hldgs Ltd Ord Shs Cl A (NU) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Nu Hldgs Ltd Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Nu Hldgs Ltd Ord Shs Cl A held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nu Hldgs Ltd Ord Shs Cl A by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.3M 244k 13.36

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Nu Hldgs Ltd Ord Shs Cl A

BlackRock
Baillie Gifford & Co
Morgan Stanley
Capital Research Global Investors
Jpmorgan Chase & Co
State Street Corporation
FMR
WCM Investment Management
Maverick Capital
Lone Pine Capital
Bank of America Corporation
Goldman Sachs Group
T. Rowe Price Associates
Technology Crossover Management X
Larch Capital Partners

View all funds holding Nu Hldgs Ltd Ord Shs Cl A